DELRAY BEACH, Fla., March 11, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Sterilization Equipment Market is projected to grow from about USD 19.39 billion in 2026 to USD 27.60 billion by 2031, at a CAGR of 7.3%.
Browse 614 market data Tables and 50 Figures spread through 550 Pages and in-depth TOC on "Sterilization Equipment Market- Global Forecast to 2031"
Sterilization Equipment Market Size & Forecast:
Sterilization Equipment Market Trends & Insights:
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=642
The market expansion is primarily driven by rising rates of hospital-acquired infections (HAIs) and by healthcare facilities improving their infection control systems. The demand is driven by several key factors, including the rising number of surgical procedures, the development of hospital infrastructure in emerging markets, and increasing regulatory scrutiny. Additionally, the increasing implementation of advanced low-temperature equipment and automated sterilization equipment is supporting market growth.
By product & service, the sterilization instruments segment accounted for the largest market share in 2025.
The market for sterilization equipment, by product & service, is segmented into sterilization instruments, sterilization services, and sterilization consumables & accessories. The growth of the sterilization instruments segment is mainly fueled by the rising incidence of hospital-acquired infections, an increasing number of surgical procedures, and strict regulatory requirements for infection control. Additionally, the global pharmaceutical and medical device industries are expanding, leading to greater demand for sterilization instruments.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=642
By end users, the medical device companies segment is projected to register the highest growth during the forecast period.
The end users in the sterilization equipment market include pharmaceutical companies, hospitals & clinics, medical device companies, and food & beverage companies. The medical device companies segment is experiencing growth due to several key factors. These include increased medical device production and strict regulations requiring sterilization validation during manufacturing. The rising complexity of medical devices, along with the growing need to maintain sterility and ensure quality during production, is driving a surge in demand for sterilization equipment among medical device companies.
North America dominated the sterilization equipment market in 2025.
The sterilization equipment market is divided into 5 major regions: Asia Pacific, Latin America, North America, Europe, and the Middle East & Africa. North America held the largest share of the sterilization equipment market in 2025. The sterilization equipment market in this region is growing due to its well-developed medical facilities, high surgical volume, and rising cases of hospital-acquired infections. The region experiences high demand for sterilization equipment due to its strong pharmaceutical and medical device manufacturing presence and strict regulations on sterilization and infection control.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=642
Top Companies in Sterilization Equipment Market:
The Top Companies in Sterilization Equipment Market include STERIS (US), Getinge AB (Sweden), Fortive (US), Solventum (US), Sotera Health (US), Cardinal Health (US), MMM Group (Germany), ANTONIO MATACHANA, S.A. (Spain), Miele Group (Germany), and Tuttnauer (Netherlands).
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Related Reports:
Sterilization Services Market - Global Forecast to 2030
Infection Control Market - Global Forecast to 2030
Surface Disinfectant Market - Global Forecast to 2030
Cleanroom Technologies Market - Global Forecast to 2031
Medical Device Manufacturing Equipment (by Production) Market - Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/sterilization-equipment-market-worth-27-60-billion-by-2031--marketsandmarkets-302710817.html
In Deutschland ist die Zahl der Organspender im vergangenen Jahr leicht gestiegen – der Bedarf bleibt jedoch deutlich höher. Nach Angaben der Deutschen Stiftung Organtransplantation (DSO) haben 985 Menschen nach ihrem Tod ein oder mehrere Organe gespendet, ein Plus von 3,4 Prozent im Vergleich zum Vorjahr. Insgesamt wurden damit mehr als 3.000 Organe übertragen. Gleichzeitig stehen laut DSO rund 8.200 Patientinnen und Patienten auf den Wartelisten und warten oft vergeblich auf ein Spenderorgan.
Die DSO und die Landesärztekammer Hessen nehmen diese Diskrepanz zum Anlass, in einer Veranstaltung in Frankfurt die Wirkung von Organspenden sichtbar zu machen. Empfängerinnen und Empfänger schildern dort, wie Transplantationen ihr Leben verändert haben, Angehörige berichten, wie sie die Entscheidung zur Spende getroffen haben. Ziel ist es, die abstrakte Statistik mit persönlichen Erfahrungen zu verbinden – und damit mehr Menschen zu motivieren, sich frühzeitig mit der eigenen Haltung zur Organspende zu beschäftigen und diese zu dokumentieren.
Ein Beispiel dafür ist Lea Jantschke. Ihre Mutter starb 2020 plötzlich an einem Hirnaneurysma, die Familie entschied sich zur Organspende. Ein Jahr später erhielt Jantschke den ersten Brief eines Empfängers der Niere ihrer Mutter. Der Kontakt erfolgt anonym, doch der emotionale Effekt ist für die Angehörigen groß. Der Brief sei für sie „wie ein kleiner Gruß“ von der Mutter gewesen, sagt die 27-Jährige. Das Schreiben habe ihrer Familie in der Trauerphase Halt gegeben, der Gedanke, die Mutter sei nun „ein Teil von dieser Familie“, habe sie besonders berührt.
Gleichzeitig macht die DSO deutlich, wie hoch der Druck auf Angehörige ist, wenn keine dokumentierte Entscheidung des Verstorbenen vorliegt. In den meisten Fällen hätten sich Betroffene zu Lebzeiten nicht mit dem Thema Organspende auseinandergesetzt, erläutert die Stiftung. Dann müssen Angehörige in einer emotionalen Ausnahmesituation und unter Zeitdruck entscheiden – häufig mit dem Ergebnis, dass sie eine Spende ablehnen, weil der Wille der verstorbenen Person nicht bekannt ist. Ärztliche Vertreter der DSO werben deshalb nachdrücklich dafür, den eigenen Standpunkt zur Organspende zu Lebzeiten festzuhalten, um sowohl Wartende auf ein Organ als auch die eigenen Angehörigen zu entlasten.
